ddPCR Reveals SARS-CoV-2 Variants in Florida Wastewater
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Wastewater was screened for the presence of functionally significant mutations in SARS-CoV-2 associated with emerging variants of concern (VOC) by ddPCR, and results accorded with sequencing of clinical samples from the same region. We propose that PCR-based screening of wastewater can provide a powerful tool for rapid and inexpensive screening of large population segments for VOC-associated mutations and can hone complementary sampling and sequencing of direct (human) test material to track emerging VOC.
Article activity feed
-
SciScore for 10.1101/2021.04.08.21255119: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources RNA was purified by multiple methods, including: Kingfisher combined with the Thermo Fisher MagMAX Viral/Pathogen II (MVP II) Nucleic Acid Isolation kit (Applied Biosystems by Thermo Fisher Scientific, Waltham, Thermo Fisher MagMAXsuggested: NoneMA); Abbott m2000 System combined with the Abbott RealTime SARS-CoV-2 assay (Abbott, Lake County, IL; Abbottsuggested: (Abbott, RRID:SCR_010477)Quality metrics were generated for raw sequence reads using fastqc v0.11.9 … SciScore for 10.1101/2021.04.08.21255119: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources RNA was purified by multiple methods, including: Kingfisher combined with the Thermo Fisher MagMAX Viral/Pathogen II (MVP II) Nucleic Acid Isolation kit (Applied Biosystems by Thermo Fisher Scientific, Waltham, Thermo Fisher MagMAXsuggested: NoneMA); Abbott m2000 System combined with the Abbott RealTime SARS-CoV-2 assay (Abbott, Lake County, IL; Abbottsuggested: (Abbott, RRID:SCR_010477)Quality metrics were generated for raw sequence reads using fastqc v0.11.9 (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/), and raw fastqs were quality filtered and trimmed (SLIDINGWINDOW:4:30 MINLEN:75 TRAILING:20) using trimmomatic v0.39 (Bolger, et al. 2014) http://www.bioinformatics.babraham.ac.uk/projects/fastqc/suggested: (FastQC, RRID:SCR_014583)trimmomaticsuggested: (Trimmomatic, RRID:SCR_011848)Sequence adapter and Phix contamination were removed using bbduk (BBMap v38.79) ( BBMapsuggested: (BBmap, RRID:SCR_016965)Variants were called using samtools mpileup v1.9 (Li, et al. 2009) and ivar variant v1.2.2 (Grubaugh, et al. 2019), and consensus assemblies were generated using samtools mpileup v1.9 (Li, et al. 2009) and ivar consensus v1.2.2 (Grubaugh, et al. 2019). samtoolssuggested: (SAMTOOLS, RRID:SCR_002105)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-